General Updates

Jubilant Pharmova Limited has announced the completion of a USFDA inspection at its Jubilant HollisterStier LLC (JHS) contract manufacturing facility in Spokane, Washington, USA. The inspection of the CMO business concluded on June 17, 2026. While the company confirmed the inspection's completion, it has not yet disclosed the specific outcome, such as any observations or regulatory actions. This update signifies a key regulatory milestone for its US operations, with investors awaiting further details on the inspection's findings.